• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Device Problems Biocompatibility (2886); Human-Device Interface Problem (2949)
Patient Problems Stroke/CVA (1770); Muscle Weakness (1967); Paralysis (1997); Speech Disorder (4415); Thrombosis/Thrombus (4440)
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, a patient was implanted with an amplatzer septal occluder; an event of device-adherent thrombus, mal-apposition of the left atrial disc, incomplete endothelization, and device explant was reported.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
The article, "novel use of the sentinel cerebral protection device during thrombosed septal occluder explant and atriclip appendage closure" was reviewed.This research article presents a case study on a (b)(6)-year-old male who presented with transient left hemi-body weakness, left facial droop, and dysarthria.The patient had experienced multiple strokes and transient ischemic attacks (tias) over a 10-year period resulting in residual right hemiplegia.Shortly after the patient's initial stroke, an ostium secundum atrial septal defect (asd) was diagnosed, followed by percutaneous closure using an amplatzer septal occluder device.Transthoracic echocardiogram with agitated saline injection showed an amplatzer septal occluder device with residual left to right interatrial shunt.Transesophageal echocardiography (tee), which had not been performed since the time of asd-occluder implant, revealed device-associated thrombus on the left atrial side and residual shunt.Over a period of 8 months, the patient was trialed on multiple anticoagulants, including warfarin and several direct oral anticoagulants, with excellent adherence, but without thrombus resolution.A decision was made to surgical explant the asd device.Given concern for embolization during explant, an sentinel¿ cerebral protection device (scpd) was placed.Excision of the amplatzer septal occluder device demonstrated mal-apposition of the left atrial disc, incomplete endothelialization, and numerous microthrombi.A bovine pericardial patch repair was used to correct the ostium secundum defect and a 45 mm atriclip appendage closure (aac) (atricure©) was deployed.The sentinel filter baskets were sequentially recaptured in reverse order and removed from the body.A notable debris burden was demonstrated by extra-corporeal basket filtration.The patient was successfully weaned of cardiopulmonary bypass (cpb) without incident.The primary author of the article is cristina nunez-pellot, md, department of medicine, morsani college of medicine, university of south florida.The correspondence author of the article is jeet j.Mehta, md, department of medicine, university of south florida, 2 tampa general cir, 5th floor cardiology, tampa, fl 33606, usa, with the corresponding email: mehtaj@usf.Edu.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key12206716
MDR Text Key262883491
Report Number2135147-2021-00294
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 07/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/21/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received06/22/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-